Literature DB >> 24705390

Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension.

Suvd Nergui1, Yoshihiro Fukumoto, Zhulanqiqige Do E, Sota Nakajima, Toru Shimizu, Shohei Ikeda, Md Elias-Al-Mamun, Hiroaki Shimokawa.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) causes elevated right ventricular (RV) systolic pressure, RV remodeling and finally RV failure to death. However, the mechanisms of RV remodeling in PH remain to be fully elucidated. METHODS AND
RESULTS: RV autopsy samples from 6 PH patients with RV failure against 3 age- and sex-matched controls were first examined. Next, RV remodeling in 2 mouse models of chronic hypoxia-induced PH with endothelial nitric oxide synthase-deficient (eNOS(-/-)) and collagenase-resistant knock-in (Col(R/R)) mice were examined. In humans, RV failure was associated with RV hypertrophy, interstitial and perivascular fibrosis, decreased RV capillary density and increased macrophage recruitment. Furthermore, immunostaining showed that perivascular matrix metalloproteinase-2 was increased in PH patients with RV failure. In animals, both hypoxic eNOS(-/-) and Col(R/R) mice developed a greater extent of RV hypertrophy, perivascular remodeling and macrophage infiltration compared with wild-type mice. Capillary rarefaction was developed in hypoxic eNOS(-/-) mice, while Col(R/R) mice were able to increase their capillary density in the RV in response to chronic hypoxia. Both mouse models showed increased autophagy even under normoxic condition.
CONCLUSIONS: These results indicate that RV remodeling occurs early during PH development through fibrosis, perivascular remodeling, capillary rarefaction and autophagy, in which the eNOS pathway and collagen metabolism might be involved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24705390     DOI: 10.1253/circj.cj-13-1586

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

Review 1.  Fibroblasts and the extracellular matrix in right ventricular disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

2.  The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension.

Authors:  Sue Gu; Claudia Mickael; Rahul Kumar; Michael H Lee; Linda Sanders; Biruk Kassa; Julie Harral; Jason Williams; Kirk C Hansen; Kurt R Stenmark; Rubin M Tuder; Brian B Graham
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

Review 3.  Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target.

Authors:  Katharina Schimmel; Kenzo Ichimura; Sushma Reddy; Francois Haddad; Edda Spiekerkoetter
Journal:  Front Cardiovasc Med       Date:  2022-05-06

Review 4.  Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Aleksandar Petrovic; Djuro Kosanovic; Akpay S Sarybaev; Norbert Weissmann; Hossein A Ghofrani; Ralph T Schermuly
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

5.  Low-Dose Aspirin Treatment Attenuates Male Rat Salt-Sensitive Hypertension via Platelet Cyclooxygenase 1 and Complement Cascade Pathway.

Authors:  Xiaoliang Jiang; Xue Liu; Xing Liu; Xianxian Wu; Pedro A Jose; Min Liu; Zhiwei Yang
Journal:  J Am Heart Assoc       Date:  2019-12-19       Impact factor: 5.501

Review 6.  Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?

Authors:  Jordy M M Kocken; Paula A da Costa Martins
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

7.  Inhaled iloprost induces long-term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy.

Authors:  Kenichiro Yasuda; Shiro Adachi; Itsumure Nishiyama; Masahiro Yoshida; Yoshihisa Nakano; Toyoaki Murohara
Journal:  Pulm Circ       Date:  2022-04-14       Impact factor: 2.886

8.  Limiting collagen turnover via collagenase-resistance attenuates right ventricular dysfunction and fibrosis in pulmonary arterial hypertension.

Authors:  Mark J Golob; Zhijie Wang; Anthony J Prostrollo; Timothy A Hacker; Naomi C Chesler
Journal:  Physiol Rep       Date:  2016-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.